261 related articles for article (PubMed ID: 10487769)
1. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.
Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF
J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756
[TBL] [Abstract][Full Text] [Related]
3. Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy.
Gaussin V; Tomlinson JE; Depre C; Engelhardt S; Antos CL; Takagi G; Hein L; Topper JN; Liggett SB; Olson EN; Lohse MJ; Vatner SF; Vatner DE
Circulation; 2003 Dec; 108(23):2926-33. PubMed ID: 14623810
[TBL] [Abstract][Full Text] [Related]
4. Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
Yan L; Vatner SF; Vatner DE
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1521-8. PubMed ID: 25193472
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart.
Vatner DE; Asai K; Iwase M; Ishikawa Y; Shannon RP; Homcy CJ; Vatner SF
Am J Cardiol; 1999 Jun; 83(12A):80H-85H. PubMed ID: 10750593
[TBL] [Abstract][Full Text] [Related]
6. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha.
Uechi M; Asai K; Osaka M; Smith A; Sato N; Wagner TE; Ishikawa Y; Hayakawa H; Vatner DE; Shannon RP; Homcy CJ; Vatner SF
Circ Res; 1998 Mar; 82(4):416-23. PubMed ID: 9506701
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Effects of Attenuating Gsα - Dependent Signaling.
Streit MR; Weiss CS; Meyer S; Ochs MM; Hagenmueller M; Riffel JH; Buss SJ; Heger T; Katus HA; Hardt SE
PLoS One; 2016; 11(1):e0146988. PubMed ID: 26811901
[TBL] [Abstract][Full Text] [Related]
8. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
9. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
Rothermel BA; McKinsey TA; Vega RB; Nicol RL; Mammen P; Yang J; Antos CL; Shelton JM; Bassel-Duby R; Olson EN; Williams RS
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3328-33. PubMed ID: 11248078
[TBL] [Abstract][Full Text] [Related]
10. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes.
Chaulet H; Lin F; Guo J; Owens WA; Michalicek J; Kesteven SH; Guan Z; Prall OW; Mearns BM; Feneley MP; Steinberg SF; Graham RM
J Mol Cell Cardiol; 2006 Apr; 40(4):540-52. PubMed ID: 16516910
[TBL] [Abstract][Full Text] [Related]
11. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.
Turki J; Lorenz JN; Green SA; Donnelly ET; Jacinto M; Liggett SB
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10483-8. PubMed ID: 8816827
[TBL] [Abstract][Full Text] [Related]
12. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
13. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
Keller K; Maass M; Dizayee S; Leiss V; Annala S; Köth J; Seemann WK; Müller-Ehmsen J; Mohr K; Nürnberg B; Engelhardt S; Herzig S; Birnbaumer L; Matthes J
Cardiovasc Res; 2015 Dec; 108(3):348-56. PubMed ID: 26464333
[TBL] [Abstract][Full Text] [Related]
14. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
15. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
16. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.
Tepe NM; Liggett SB
FEBS Lett; 1999 Sep; 458(2):236-40. PubMed ID: 10481072
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice.
Engelhardt S; Hein L; Keller U; Klämbt K; Lohse MJ
Circ Res; 2002 Apr; 90(7):814-9. PubMed ID: 11964375
[TBL] [Abstract][Full Text] [Related]
18. Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression.
Gao XM; Agrotis A; Autelitano DJ; Percy E; Woodcock EA; Jennings GL; Dart AM; Du XJ
Endocrinology; 2003 Sep; 144(9):4097-105. PubMed ID: 12933684
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
20. Propranolol prevents enhanced stress signaling in Gs alpha cardiomyopathy: potential mechanism for beta-blockade in heart failure.
Karoor V; Vatner SF; Takagi G; Yang G; Thaisz J; Sadoshima J; Vatner DE
J Mol Cell Cardiol; 2004 Feb; 36(2):305-12. PubMed ID: 14871558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
